Clinical features and prognostic factors in childhood pneumococcal meningitis

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 1, 2008, Pages 48-53

  Chao, Yen Nan ^a   Chiu, Nan Chang ^a   Huang, Fu Yuan ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Child; Infant; Meningitis, bacterial; Mortality; Prognosis; Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CEPHALOSPORIN; DEXAMETHASONE; GLUCOSE; PENICILLIN G; VANCOMYCIN;

ARTICLE; BACTERIAL MENINGITIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENDOTRACHEAL INTUBATION; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFANT; LABORATORY TEST; MALE; MONOTHERAPY; MORBIDITY; MORTALITY; NEUROLOGICAL COMPLICATION; PROGNOSIS; SKULL BASE; STATISTICAL SIGNIFICANCE;

CEREBROSPINAL FLUID; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOSE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, PNEUMOCOCCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 44849138827     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Swartz MN. Bacterial meningitis - a view of the past 90 years. N Engl J Med. 2004;351:1826-8.
2. El Bashir H, Laundy M, Booy R. Diagnosis and treatment of bacterial meningitis. Arch Dis Child. 2003;88:615-20.
3. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2003;(3):CD004405.
4. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, et al. Bacterial meningitis in the United States in 1995. N Engl J Med. 1997;337:970-6.
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk susceptibility tests. Approved standard, 8th ed. CLSI document M2-A8. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
6. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. 1998;102:1087-97.
7. Yu CH, Chiu NC, Huang FY. Invasive pneumococcal infection in children. Southeast Asian J Trop Med Public Health. 2001:32:126-31.
8. Chang Chien HY, Chiu NC, Li WC, Huang FY. Characteristics of neonatal bacterial meningitis in a teaching hospital in Taiwan from 1984-1997. J Microbiol Immunol Infect. 2000:33:100-4.
9. Saha SK, Darmstadt GL, Yamanaka N, Billal DS, Nasreen T, Islam M, et al. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J. 2005;24:1093-8.
10. Täuber MG, Kennedy SL, Tureen JH, Lowenstein DH. Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am J Pathol. 1992;141:53-60.
11. Giampaolo C, Scheid M, Boyd J, Savory J, Sande M, Wills M. Leukocyte and bacterial interrelationships in experimental meningitis. Ann Neurol. 1981;9:328-33.
12. Felgenhauer K, Kober D. Apurulent bacterial meningitis (compartmental leucopenia in purulent meningitis). J Neurol. 1985;232:157-61.
13. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. Brain. 2003;126:1015-25.
14. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 1997;278:925-31.
15. Kanra GY, Ozen H, Seçmeer G, Ceyhan M, Ecevit Z, Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J. 1995; 14:490-4.
16. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet. 2002;360:211-8.
17. McIntyre PB, Macintyre CR, Gilmour R, Wang H. A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitis. Arch Dis Child. 2005;90:391-6.
18. Huang FY, Chiu NC, Liu SC. Penicillin-resistant pneumococcal infections in children. J Formos Med Assoc. 1997:96:414-8.
19. Lu CY, Lee PI, Hsueh PR, Chang SC, Chiu TF, Lin HC, et al. Penicillin-nonsusceptible Streptococcus pneumoniae infections in children. J Microbiol Immunol Infect. 1999:32:179-86.
20. Kellner JD, Scheifele DW, Halperin SA, Lebel MH, Moore D, Le Saux N, et al; Canadian Paediatric Society/Centre for Infectious Disease Prevention and Control Immunization Monitoring Program. Outcome of penicillin-nonsusceptible Streptococcus pneumoniae meningitis: a nested casecontrol study. Pediatr Infect Dis J. 2002;21:903-10.
21. Tan, TQ. Antibiotic resistant infections due to Streptococcus pneumoniae: impact on therapeutic options and clinical outcome. Curr Opin Infect Dis. 2003;16:271-7.
22. Koedel U, Scheid WM, Pfister HW. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis. 2002:2:721-36.